Top Story

Trial Scorecard: EXACT-HF

Cardiology Today, July 2015

Study of effectiveness of allopurinol for relieving symptoms in patients with HF and high blood uric acid levels.

FDA NewsPublication Exclusive

FDA advisory panel backs approval of PCSK9 inhibitors

Cardiology Today, July 2015
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted in June to recommend approval of two PCSK9 inhibitors for the reduction of LDL in certain…
Trial Scorecards

Trial Scorecard: VADT

Cardiology Today, July 2015
Researchers assessed whether tight control of HbA1c in veterans with diabetes is associated with improved CV outcomes.
Trial Scorecards

Trial Scorecard: TRANSLATE-ACS

Cardiology Today, July 2015
Analysis of patient adherence to medications 6 weeks after MI.
Trial Scorecards

Trial Scorecard: ENGAGE

Cardiology Today, July 2015
Registry to gauge safety and effectiveness of Endurant stent graft (Medtronic) in real-world patients with abdominal aortic aneurysm.
More News Headlines »
CME
Cardiology Case Consults

The Patient with Acute Coronary Syndrome

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with acute coronary syndrome.
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
CME
Antiplatelet Agents in ACS Distinguishing Characteristics Safety and Efficacy

Antiplatelet Agents in ACS: Distinguishing Characteristics, Safety, and Efficacy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
morganatic-roan